The findings suggest that intranasally delivered FGF-1 may reverse type 2 diabetes by targeting dysfunctional glucose-sensing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible resultsResults that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback